Literature DB >> 25692442

Surgical management of perforated gastrointestinal posttransplantation lymphoproliferative disorder after heart transplantation.

Hideki Osawa1, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori.   

Abstract

Posttransplantation lymphoproliferative disorder (PTLD) is a relatively rare and life-threatening complication after organ transplantation. From 1999 to 2012, 45 adult patients underwent heart transplantation at our hospital. Two of the patients developed PTLD after transplantation and required emergency surgery due to intestinal perforation. These cases were informative regarding the adequate surgical management of such cases. Both cases revealed Epstein-Barr virus-related PTLD. The optimal treatment of PTLD remains controversial, and PTLD with gastrointestinal perforation could be critical because the patients are already debilitated and immunocompromised after transplantation. Therefore, the nonspecific abdominal symptoms can be diagnostic for PTLD, and proper surgical intervention should be performed immediately. We present these two suggestive and rare cases in regard to the management of perforation with PTLD and a review of literature.

Entities:  

Keywords:  Intestinal perforation; Lymphoma; Lymphoproliferative disorder; Posttransplantation; Transplantation

Mesh:

Year:  2015        PMID: 25692442      PMCID: PMC4337454          DOI: 10.9738/INTSURG-D-13-00270.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  28 in total

Review 1.  Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

Authors:  Deepa Jagadeesh; Bruce A Woda; Jacqueline Draper; Andrew M Evens
Journal:  Curr Treat Options Oncol       Date:  2012-03

2.  Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.

Authors:  Brandon E Kremer; Ran Reshef; Jamal G Misleh; Jason D Christie; Vivek N Ahya; Nancy P Blumenthal; Robert M Kotloff; Denis Hadjiliadis; Edward A Stadtmauer; Stephen J Schuster; Donald E Tsai
Journal:  J Heart Lung Transplant       Date:  2011-11-23       Impact factor: 10.247

Review 3.  Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.

Authors:  C V Paya; J J Fung; M A Nalesnik; E Kieff; M Green; G Gores; T M Habermann; P H Wiesner; J L Swinnen; E S Woodle; J S Bromberg
Journal:  Transplantation       Date:  1999-11-27       Impact factor: 4.939

4.  Impact of enterococcus on immunocompetent and immunosuppressed patients with perforation of the small or large bowel.

Authors:  Magnus Friedrich Kaffarnik; Max Urban; Ulrich Theodor Hopt; Stefan Utzolino
Journal:  Technol Health Care       Date:  2012       Impact factor: 1.285

Review 5.  Predicting the risk and diminishing the consequences of anastomotic leakage after anterior resection for rectal cancer.

Authors:  B J Moran
Journal:  Acta Chir Iugosl       Date:  2010

6.  A multicenter randomized clinical trial of primary anastomosis or Hartmann's procedure for perforated left colonic diverticulitis with purulent or fecal peritonitis.

Authors:  Christian Eugen Oberkofler; Andreas Rickenbacher; Dimitri Aristotle Raptis; Kuno Lehmann; Peter Villiger; Christian Buchli; Felix Grieder; Hans Gelpke; Marco Decurtins; Adrien A Tempia-Caliera; Nicolas Demartines; Dieter Hahnloser; Pierre-Alain Clavien; Stefan Breitenstein
Journal:  Ann Surg       Date:  2012-11       Impact factor: 12.969

7.  Lymphomas after solid organ transplantation: a collaborative transplant study report.

Authors:  Gerhard Opelz; Bernd Döhler
Journal:  Am J Transplant       Date:  2004-02       Impact factor: 8.086

8.  Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids.

Authors:  R A McDonald; J M Smith; M Ho; R Lindblad; D Ikle; P Grimm; R Wyatt; M Arar; D Liereman; N Bridges; W Harmon
Journal:  Am J Transplant       Date:  2008-05       Impact factor: 8.086

9.  Aggressive posttransplant lymphoproliferative disease in a renal transplant patient treated with alemtuzumab.

Authors:  Mahvish Muzaffar; Asma Taj; Shobha Ratnam
Journal:  Am J Ther       Date:  2010 Nov-Dec       Impact factor: 2.688

10.  T-cell and NK-cell posttransplantation lymphoproliferative disorders.

Authors:  Steven H Swerdlow
Journal:  Am J Clin Pathol       Date:  2007-06       Impact factor: 2.493

View more
  2 in total

1.  Anesthesia management of surgery for sigmoid perforation and acute peritonitis patient following heart transplantation: case report.

Authors:  Xu-Li Yang; Shu-Hong Dai; Juan Zhang; Jing Zhang; Yan-Jun Liu; Yan Yang; Yu-E Sun; Zheng-Liang Ma; Xiao-Ping Gu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Treatment dilemma for survivors of rituximab-induced bowel perforation in the setting of post-transplant lymphoproliferative disorder.

Authors:  Brianne J Sullivan; Grace J Kim; Gabriel Sara
Journal:  BMJ Case Rep       Date:  2018-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.